Camp4 Therapeutics (CAMP) Capital Leases (2023 - 2025)

Camp4 Therapeutics has reported Capital Leases for 3 years, with the latest figure at $47000.0 in Q3 2025.

• Quarterly Capital Leases fell 45.98% year-over-year to $47000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $47000.0 (down 45.98% YoY) and the FY2024 annual result came in at $70000.0, down 52.7% from the prior year.
• Capital Leases slipped to $47000.0 in Q3 2025 per CAMP's latest filing, from $59000.0 in the prior quarter.
• Over five years, Capital Leases peaked at $148000.0 in Q4 2023 and troughed at $47000.0 in Q3 2025.
• A 3-year average of $78166.7 and a median of $64500.0 in 2024 frame the typical range for Capital Leases.
• The sharpest annual moves came in 2024 and 2025: Capital Leases sank 52.7% in 2024, then tumbled 45.98% in 2025.
• Over 3 years, Capital Leases stood at $148000.0 in 2023, then tumbled by 52.7% to $70000.0 in 2024, then plunged by 32.86% to $47000.0 in 2025.
• According to Business Quant data, Capital Leases over the past three periods registered $47000.0, $59000.0, and $58000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.